| Could this be the solution to chronic pain—and the opioid epidemic? National Geographic: Ryan Marino, assistant professor at the School of Medicine, discussed new research suggesting monoclonal antibodies—used to protect the vulnerable from COVID-19—may provide non-addictive, long-lasting pain relief for a variety of conditions. |
